Literature DB >> 12112467

Characterization of transgene expression and Cre recombinase activity in a panel of Thy-1 promoter-Cre transgenic mice.

Katrina D Campsall1, Chantal J Mazerolle, Yves De Repentingy, Rashmi Kothary, Valerie A Wallace.   

Abstract

The regulatory elements of the murine Thy1.2 gene were used to drive Cre recombinase expression in the nervous system (NS) of transgenic mice. Eleven Thy1-Cre lines exhibited transgene expression in several regions of the central and peripheral nervous systems, including the cerebral cortex, cerebellum, spinal cord, retina, and dorsal root ganglion. Thy1-Cre expression also resulted in region-specific activation of Cre reporter transgenes. Although Thy-1 expression is normally initiated in postmitotic neurons in the perinatal period, we show that the Thy-1.2 expression cassette drives Cre expression in immature proliferative zones in the NS as early as embryonic day 11 and in non-neural tissue. The Thy1.2 transgene cassette, therefore, does not impart transgene expression that is restricted to the NS or to postmitotic neurons within the NS. This panel of Thy1-Cre transgenic mice, however, will be useful reagents for the ablation of genes whose transcripts are spatially or temporally restricted in the developing NS. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112467     DOI: 10.1002/dvdy.10092

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  20 in total

1.  Cell autonomy of DSCAM function in retinal development.

Authors:  Peter G Fuerst; Freyja Bruce; Ryan P Rounds; Lynda Erskine; Robert W Burgess
Journal:  Dev Biol       Date:  2011-10-29       Impact factor: 3.582

Review 2.  Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype.

Authors:  John E Bradley; Gustavo Ramirez; James S Hagood
Journal:  Biofactors       Date:  2009 May-Jun       Impact factor: 6.113

3.  Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.

Authors:  Xuan Ye; Tuancheng Feng; Prasad Tammineni; Qing Chang; Yu Young Jeong; David J Margolis; Huaibin Cai; Alexander Kusnecov; Qian Cai
Journal:  J Neurosci       Date:  2017-02-03       Impact factor: 6.167

4.  Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy.

Authors:  Sophie Belin; Francesca Ornaghi; Ghjuvan'Ghjacumu Shackleford; Jie Wang; Cristina Scapin; Camila Lopez-Anido; Nicholas Silvestri; Neil Robertson; Courtney Williamson; Akihiro Ishii; Carla Taveggia; John Svaren; Rashmi Bansal; Markus H Schwab; Klaus Nave; Pietro Fratta; Maurizio D'Antonio; Yannick Poitelon; M Laura Feltri; Lawrence Wrabetz
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

Review 5.  Cardiac fibroblasts: more than mechanical support.

Authors:  Stefanie A Doppler; Catarina Carvalho; Harald Lahm; Marcus-André Deutsch; Martina Dreßen; Nazan Puluca; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice.

Authors:  Noah R Johnson; Carlo Condello; Shenheng Guan; Abby Oehler; Julia Becker; Marta Gavidia; George A Carlson; Kurt Giles; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

7.  Generation of BAF53b-Cre transgenic mice with pan-neuronal Cre activities.

Authors:  Xiaoming Zhan; Mou Cao; Andrew S Yoo; Zilai Zhang; Lei Chen; Gerald R Crabtree; Jiang I Wu
Journal:  Genesis       Date:  2015-06-23       Impact factor: 2.487

8.  Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult.

Authors:  Shaefali P Rodgers; Heather A Born; Pritam Das; Joanna L Jankowsky
Journal:  Mol Neurodegener       Date:  2012-06-18       Impact factor: 14.195

9.  Conditional gene targeting: dissecting the cellular mechanisms of retinal degenerations.

Authors:  Yun-Zheng Le
Journal:  J Ophthalmol       Date:  2010-12-29       Impact factor: 1.909

10.  Transgenic mouse model for the formation of Hirano bodies.

Authors:  Sangdeuk Ha; Ruth Furukawa; Michael Stramiello; John J Wagner; Marcus Fechheimer
Journal:  BMC Neurosci       Date:  2011-10-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.